Post by
woundedknee on Sep 28, 2015 8:28am
Today's NR
Happen to read today's NR and see that this company is doing research on Bladder Cancer. Anyone ever look at V.TLT. They are developing a novel treatment for Bladder Cancer as well. Don't get me wrong..I am not pumping the stock; just saying it may be of interest to some here. GL
Comment by
ragingbull1327 on Sep 28, 2015 1:22pm
I wonder if the FDA see themselves as a detriment to society? On one hand, they are there to ensure the safety and efficacy of treatments that combat awful diseases, and then on the other hand, I walk to the corner store and see Monster Energy drinks and cigarettes. Brilliant game plan.....
Comment by
rgonlyfactspls on Sep 28, 2015 1:42pm
Theralase -- Will take a veeeery long period of "keeping-an-eye-on" re their NMIBC treatment in development. At the stage of submitting an application to progress to Phase 1b clinical trials for NMIBC. All the best though! -- https://theralase.com/pressrelease/theralase-submits-clinical-trial-application-to-health-canada-for-approval/
Comment by
HighteawithIntrepid on Sep 28, 2015 3:40pm
We ticked another box, rounded another base. Be happy. We're 150 days away from that final thumbs up and the largest single day price bump since day 1. Consolidations don't count. HT
Comment by
DamnYankees on Sep 28, 2015 3:46pm
Hello HT. Can you please start the same countdown at the Therelaser discussion board. If there is one. Assuming that they get fast tracked everywhere with no delays I have them at 5,109 days to their P3 submission. That is about 8 financings and 3 management changes to approval. I am confident that they will appreciate your daily box ticking
Comment by
loveshackdave on Sep 28, 2015 3:45pm
Ha! Oh man, I mixed them up with Viventia, which is phase III. Nevermind, I've never heard of Theralase.